HIV Citation List: December 23 - January 5, 2010
Pubmed citations:
1. Anti-retroviral activity of TRIM5alpha. Nakayama EE, Shioda T. Rev Med Virol. 2010 Jan 4. [Epub ahead of print]PMID: 20049904
2. Pradimicin S, a highly-soluble non-peptidic small-size carbohydrate-binding antibiotic, is an anti-HIV drug lead for both microbicidal and systemic use. Balzarini J, François K, Van Laethem K, Hoorelbeke B, Renders M, Auwerx J, Liekens S, Oki T, Igarashi Y, Schols D. Antimicrob Agents Chemother. 2010 Jan 4. [Epub ahead of print]PMID: 20047920
3. A sensitive HIV-1 envelope induced fusion assay identifies fusion enhancement of thrombin. Cheng DC, Zhong GC, Su JX, Liu YH, Li Y, Wang JY, Hattori T, Ling H, Zhang FM. Biochem Biophys Res Commun. 2009 Dec 31. [Epub ahead of print]PMID: 20045672
4. Synthesis and Structure-Activity Relationships of Azamacrocyclic C-X-C Chemokine Receptor 4 Antagonists: Analogues Containing a Single Azamacrocyclic Ring are Potent Inhibitors of T-Cell Tropic (X4) HIV-1 Replication. Bridger GJ, Skerlj RT, Hernandez-Abad PE, Bogucki DE, Wang Z, Zhou Y, Nan S, Boehringer EM, Wilson T, Crawford J, Metz M, Hatse S, Princen K, De Clercq E, Schols D. J Med Chem. 2009 Dec 31. [Epub ahead of print]PMID: 20043638
5. Pharmacokinetics and Pharmacodynamics of GS-9350: A Novel Pharmacokinetic Enhancer Without Anti-HIV Activity. Mathias AA, German P, Murray BP, Wei L, Jain A, West S, Warren D, Hui J, Kearney BP. Clin Pharmacol Ther. 2009 Dec 30. [Epub ahead of print]PMID: 20043009
6. Integrase Inhibitors: A Novel Class of Antiretroviral Agents (January) (CE). Schafer JJ, Squires KE. Ann Pharmacother. 2009 Dec 29. [Epub ahead of print]PMID: 20040702
7. Oxovanadium(IV) Cyclam and Bicyclam Complexes: Potential CXCR4 Receptor Antagonists. Ross A, Soares DC, Covelli D, Pannecouque C, Budd L, Collins A, Robertson N, Parsons S, De Clercq E, Kennepohl P, Sadler PJ. Inorg Chem. 2009 Dec 29. [Epub ahead of print]PMID: 20039648
8. Stage-Dependent Inhibition of HIV-1 Replication by Antiretroviral Drugs in Cell Culture. Donahue DA, Sloan RD, Kuhl BD, Bar-Magen T, Schader SM, Wainberg MA. Antimicrob Agents Chemother. 2009 Dec 28. [Epub ahead of print]PMID: 20038621
9. Highly functionalized daphnane diterpenoids from Trigonostemon thyrsoideum. Zhang L, Luo RH, Wang F, Jiang MY, Dong ZJ, Yang LM, Zheng YT, Liu JK. Org Lett. 2010 Jan 1;12(1):152-5.PMID: 19968236
10. A high-affinity inhibitor of human CD59 enhances complement-mediated virolysis of HIV-1: implications for treatment of HIV-1/AIDS. Hu W, Yu Q, Hu N, Byrd D, Amet T, Shikuma C, Shiramizu B, Halperin JA, Qin X. J Immunol. 2010 Jan 1;184(1):359-68. Epub 2009 Dec 2.PMID: 19955519
11. Total synthesis, characterization, and conformational analysis of the naturally occurring hexadecapeptide integramide A and a diastereomer. De Zotti M, Damato F, Formaggio F, Crisma M, Schievano E, Mammi S, Kaptein B, Broxterman QB, Felock PJ, Hazuda DJ, Singh SB, Kirschbaum J, Brückner H, Toniolo C. Chemistry. 2010 Jan 4;16(1):316-27.PMID: 19937615
ISI Web of Knowledge citations:
12. Quantifying the relationship between HIV-1 susceptibility to CCR5 antagonists and virus affinity for antagonist-occupied co-receptor. Buontempo, PJ; Wojcik, L; Buontempo, CA; Ogert, RA; Strizki, JM; Howe, JA; Ralston, R. VIROLOGY, 2009; 395(2): 268-279.
13. Characterisation of a haemagglutinin from Hokkaido red bean (Phaseolus vulgaris cv. Hokkaido red bean). Wong, JH Wan, CT; Ng, TB. L OF THE SCIENCE OF FOOD AND AGRICULTURE, 2010; 90(1): 70-77.
14. The histone deacetylase inhibitor ITF2357 decreases surface CXCR4 and CCR5 expression in CD4+ T-cells and monocytes and induces latent HIV-1 expression in vitro. Matalon, S; Palmer, BE; Nold, MF; Furlan, A; Fossati, G; Mascagni, P; Dinarello, CA. CYTOKINE, 2009; 48(1-2): 61-61.
15. Structure of HIV-1 Reverse Transcriptase with the Inhibitor beta-Thujaplicinol Bound at the RNase H Active Site. Himmel, DM; Maegley, KA; Pauly, TA; Bauman, JD; Das, K; Dharia, C; Clark, AD; Ryan, K; Hickey, MJ; Love, RA; Hughes, SH; Bergqvist, S; Arnold, E. STRUCTURE, 2009; 17(12): 1625-1635.
16. Ganoderma lucidum: A Potent Pharmacological Macrofungus. Sanodiya, BS; Thakur, GS; Baghel, RK; Prasad, GBKS; Bisen, PS. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2009; 10(8): 717-742.